Services
Education
George Washington University Law School (J.D., 2009, high honors, Order of the Coif) Georgetown University (B.A., 2006, magna cum laude)Admissions
- District of Columbia and Virginia
- United States Supreme Court
- United States Court of Appeals for the Eleventh Circuit
Accolades
- Henry R. Berger Award for Excellence in Tort Law, George Washington University Law School, 2009
- Named “Rising Star”, Washington DC edition of Super Lawyers, 2018 and 2019
Memberships
- Defense Research Institute (DRI)
Insights & Events
By Andrew Reissaus and Aleksandra Rybicki
Firm client Legal Counsel for the Elderly highlighted the work of two groups of Firm attorneys in its monthly newsletter Pro Bono Publico. In one matter, Lauren Prease, Andrew Reissaus, and James Sullivan obtained information through an FOIA…
Kapps v. Biosense Webster: Who Is Liable When a Reprocessed Medical Device Causes Injury?
publication | January 1, 2012A Washington Legal Foundation Working Paper, co-authored by Stephen A. Klein and Andrew L. Reissaus, this article discusses one of the first cases to address the application of traditional product liability theories in the context of a reprocessed medical device, in which both the original manufacturer and the reprocessor are defendants.
Cases
The Zometa Cases
- Precedent
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- Class Action Defense
- January 27, 2015
The core business model for products-liability plaintiffs’ lawyers depends increasingly on first amassing an inventory of claimants via consolidated state and federal proceedings, and then threatening big verdicts in early trials involving cherry-picked claims in favorable…
Federal Court Holds N.J. Statute Precludes Punitive Damages and “fraud” Exception is Preempted
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- July 31, 2018
A federal district court judge has precluded plaintiffs from seeking punitive damages at trial in a product liability case involving one of Novartis Pharmaceuticals Corporation’s cancer therapies. On July 31, 2018, Judge Robin L. Rosenberg of…
11th Circuit Affirms Summary Judgment in Reclast Case Based on Daubert Exclusion of Expert Testimony
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- April 30, 2018
The Eleventh Circuit affirmed Novartis’s summary judgment win in Jones v. Novartis Pharm. Corp., No. 17-1106 (11th Cir. Apr. 30, 2018). The Court, in a per curiam opinion issued only three weeks after oral argument, affirmed…
Novartis Obtains Summary Judgment on Daubert Exclusion of Expert’s Testimony in Reclast Case
- Case
- Toxic Torts & Products Liability
- February 10, 2017
Judge Virginia Hopkins of the U.S. District Court for the Northern District of Alabama granted Novartis’s motion for summary judgment and entered final judgment in Jones v. Novartis Pharmaceuticals Corp., No. 2:13-cv-00624-VEH, 2017 WL 553134 (N.D.…